• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BDX

BCAL DIAGNOSTICS LIMITED - Corporate Spotlight

0.00% ! 6.7¢
Market Cap $24.51M  !

BCAL Diagnostics Limited is an Australia-based biotechnology company dedicated to... BCAL Diagnostics Limited is an Australia-based biotechnology company dedicated to advancing early and accurate breast cancer detection. The Company’s core activity is the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, which is available to all women. Its non-invasive blood test, BREASTEST plus, is the product in the Company’s BREASTEST range of non-invasive, lipid-based breast cancer diagnostics. BREASTEST plus is a class blood test that measures a panel of lipids, using Liquid Chromatography Mass Spectrometry, to identify a lipidomic breast cancer signature. BREASTEST plus is a rule-out test that has been designed to be used in women with dense breasts and alongside mammography to improve screening and diagnostic outcomes for women.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

No Corporate Spotlight currently available.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
6.7¢
Change
0.000(0.00%)
Mkt cap ! $24.51M
Open High Low Value Volume
6.7¢ 6.7¢ 6.7¢ $1.648K 24.60K

Buyers (Bids)

No. Vol. Price($)
1 15396 6.7¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 5714 1
View Market Depth
Last trade - 15.47pm 25/07/2025 (20 minute delay) ?
BDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.